JP2007526238A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526238A5
JP2007526238A5 JP2006532814A JP2006532814A JP2007526238A5 JP 2007526238 A5 JP2007526238 A5 JP 2007526238A5 JP 2006532814 A JP2006532814 A JP 2006532814A JP 2006532814 A JP2006532814 A JP 2006532814A JP 2007526238 A5 JP2007526238 A5 JP 2007526238A5
Authority
JP
Japan
Prior art keywords
group
folic acid
immunogen
drug
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006532814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/014097 external-priority patent/WO2004100983A2/en
Publication of JP2007526238A publication Critical patent/JP2007526238A/ja
Publication of JP2007526238A5 publication Critical patent/JP2007526238A5/ja
Pending legal-status Critical Current

Links

JP2006532814A 2003-05-06 2004-05-06 マクロファージまたは葉酸受容体を標的とする狼瘡治療法 Pending JP2007526238A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46833003P 2003-05-06 2003-05-06
PCT/US2004/014097 WO2004100983A2 (en) 2003-05-06 2004-05-06 Treatment of lupus targeting the macrophages or the folate receptor

Publications (2)

Publication Number Publication Date
JP2007526238A JP2007526238A (ja) 2007-09-13
JP2007526238A5 true JP2007526238A5 (cg-RX-API-DMAC7.html) 2009-01-08

Family

ID=33452201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006532814A Pending JP2007526238A (ja) 2003-05-06 2004-05-06 マクロファージまたは葉酸受容体を標的とする狼瘡治療法

Country Status (5)

Country Link
US (2) US20060204565A1 (cg-RX-API-DMAC7.html)
EP (1) EP1622646B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007526238A (cg-RX-API-DMAC7.html)
CA (1) CA2524441C (cg-RX-API-DMAC7.html)
WO (1) WO2004100983A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158532A0 (en) 2001-05-02 2004-05-12 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
US8043603B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US8043602B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
ES2438008T3 (es) 2002-05-06 2014-01-15 Endocyte, Inc. Agentes de formación de imágenes dirigidos a vitaminas
JP4680185B2 (ja) * 2003-05-30 2011-05-11 パーデュー・リサーチ・ファウンデーション アテローム性動脈硬化症の診断法
CN101098854B (zh) 2004-07-23 2012-12-05 恩多塞特公司 二价连接体及其轭合物
CA2592302C (en) * 2004-12-23 2013-10-29 Purdue Research Foundation Positron emission tomography imaging method
JP5175723B2 (ja) * 2005-07-05 2013-04-03 パーデュー・リサーチ・ファウンデーション 単球介在性疾患を治療するための組成物の調製
US8795633B2 (en) 2005-09-23 2014-08-05 Purdue Research Foundation Multiphoton in vivo flow cytometry method and device
CA2651866C (en) 2006-05-11 2014-10-28 Universiteit Gent Sialoadhesin-related compositions and methods
WO2008127298A2 (en) * 2006-10-24 2008-10-23 Subroto Chatterjee Staphylococcal enterotoxin b peptide compositions and methods of use
JP2010509570A (ja) 2006-11-03 2010-03-25 パーデュー・リサーチ・ファウンデーション エクスビボフローサイトメトリーの方法および装置
US8586595B2 (en) * 2007-02-07 2013-11-19 Purdue Research Foundation Positron emission tomography imaging method
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN104127878A (zh) 2007-03-14 2014-11-05 恩多塞特公司 结合配体连接的微管溶素递药缀合物
WO2008148001A2 (en) * 2007-05-25 2008-12-04 Purdue Research Foundation Method of imaging localized infections
BRPI0812970A2 (pt) 2007-06-25 2019-09-24 Endocyte Inc conjugados contendo espaçadores hidrofílicos
EP2209374B1 (en) 2007-10-25 2014-12-03 Endocyte, Inc. Tubulysins and processes for preparing
WO2011150392A1 (en) 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
EA201590622A1 (ru) 2012-10-16 2015-10-30 Эндосайт, Инк. Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения
EP3334466B1 (en) 2015-08-14 2020-05-13 Endocyte, Inc. Method of imaging with a chelating compound
CN114377017A (zh) * 2020-10-21 2022-04-22 复旦大学 叶酸和叶酸修饰在诱导B细胞免疫耐受和靶向mIgM阳性表达的B细胞淋巴瘤中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5108921A (en) * 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
ATE211394T1 (de) * 1997-06-20 2002-01-15 Tanox Pharma B V Anti-cd40l immunotoxine zur behandlung von krankheiten
CA2321136A1 (en) * 1998-02-17 1999-08-19 Medarex, Inc. Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
DZ3332A1 (fr) * 2000-03-31 2001-10-11 Purdue Research Foundation Methode de traitement a l'aide de conjugues ligand-immunogene
IL158532A0 (en) * 2001-05-02 2004-05-12 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
DE60234782D1 (de) * 2001-09-28 2010-01-28 Purdue Research Foundation Behandlungsverfahren mit liganden-immunogenkonjugaten
DE60229781D1 (de) * 2001-12-21 2008-12-18 Serono Lab Raf/ras-bindende verbindungen
ES2438008T3 (es) * 2002-05-06 2014-01-15 Endocyte, Inc. Agentes de formación de imágenes dirigidos a vitaminas

Similar Documents

Publication Publication Date Title
JP2008514290A5 (cg-RX-API-DMAC7.html)
EE200300295A (et) Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
EE200300312A (et) Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
IL183274A0 (en) Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
MA29346B1 (fr) Formulations pharmaceutiques gastrorésistantes à base de rifaximine
WO2004112711A3 (en) Oral extended-release composition
JP2010536849A5 (cg-RX-API-DMAC7.html)
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
CY1112184T1 (el) Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
RU2005126412A (ru) Сор1 для лечения воспалительных заболеваний кишечника
WO2005111002A3 (de) Substituierte cycloalkylderivate zur behandlung von atemswegerkrankungen
CA2524441A1 (en) Treatment of lupus targeting the macrophages or the folate receptor
JP2007523135A5 (cg-RX-API-DMAC7.html)
JP2006514116A5 (cg-RX-API-DMAC7.html)
WO2006009874A3 (en) Methods and compositions for treatment of excess nitric oxide or cyanide toxicity
WO2007030944A3 (en) Methods of cardioprotection using dichloroacetate in combination with an inotrope
ATE525359T1 (de) Modulatoren der aktivität des glucokortikoidrezeptors von ap-1 und/oder von nf- kb und anwendung davon
JP2009516719A5 (cg-RX-API-DMAC7.html)
JP2006527741A5 (cg-RX-API-DMAC7.html)
JP2010524906A5 (cg-RX-API-DMAC7.html)
WO2005056520A8 (en) Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
JP2005505605A5 (cg-RX-API-DMAC7.html)
JP2010526884A5 (cg-RX-API-DMAC7.html)
JP2003246730A5 (cg-RX-API-DMAC7.html)